173 related articles for article (PubMed ID: 36677683)
1. Synthesis and In Vitro Anticancer Evaluation of Flavone-1,2,3-Triazole Hybrids.
Németh-Rieder A; Keglevich P; Hunyadi A; Latif AD; Zupkó I; Hazai L
Molecules; 2023 Jan; 28(2):. PubMed ID: 36677683
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and cytotoxic evaluation of novel indenoisoquinoline-substituted triazole hybrids.
Pham Thi T; Le Nhat TG; Ngo Hanh T; Luc Quang T; Pham The C; Dang Thi TA; Nguyen HT; Nguyen TH; Hoang Thi P; Van Nguyen T
Bioorg Med Chem Lett; 2016 Aug; 26(15):3652-7. PubMed ID: 27342752
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and antiproliferative activity of functionalized flavone-triazole-tetrahydropyran conjugates against human cancer cell lines.
Ahmed N; Konduru NK; Ahmad S; Owais M
Eur J Med Chem; 2014 Jul; 82():552-64. PubMed ID: 24941129
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Preclinical Evaluation of Indole Triazole Conjugates as Microtubule Targeting Agents that are Effective against MCF-7 Breast Cancer Cell Lines.
Yele V; Pindiprolu SKSS; Sana S; Ramamurty DSVNM; Madasi JRK; Vadlamani S
Anticancer Agents Med Chem; 2021; 21(8):1047-1055. PubMed ID: 32981511
[TBL] [Abstract][Full Text] [Related]
5. A Novel Series of N-aryltriazole and N-acridinyltriazole Hybrids as Potential Anticancer Agents.
Rono CK; Darkwa J; Meyer D; Makhubela BCE
Curr Org Synth; 2019; 16(6):900-912. PubMed ID: 31984911
[TBL] [Abstract][Full Text] [Related]
6. Bis-triazole-containing Compounds with Anticancer Potential: A Short Review.
Gao M; Diao Q; Gao F; Sun X; Xiao J
Curr Top Med Chem; 2021; 21(18):1674-1691. PubMed ID: 34323190
[TBL] [Abstract][Full Text] [Related]
7. Moxifloxacin-isatin Hybrids Tethered by 1,2,3-triazole and their Anticancer Activities.
Yang M; Liu H; Zhang Y; Wang X; Xu Z
Curr Top Med Chem; 2020; 20(16):1461-1467. PubMed ID: 31994464
[TBL] [Abstract][Full Text] [Related]
8. Click chemistry-assisted synthesis of novel aminonaphthoquinone-1,2,3-triazole hybrids and investigation of their cytotoxicity and cancer cell cycle alterations.
Gholampour M; Ranjbar S; Edraki N; Mohabbati M; Firuzi O; Khoshneviszadeh M
Bioorg Chem; 2019 Jul; 88():102967. PubMed ID: 31078767
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and Biological Evaluation of New 1,2,3-Triazole Derivatives of the Chrysin Flavonoid as Anticancer Agents.
Noole V; Krishna T; Godeshala S; Meraji S; Rege K; Reddy CK; Kedika B
Anticancer Agents Med Chem; 2022; 22(1):160-168. PubMed ID: 33719963
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of Novel Fluoro Phenyl Triazoles
Aguilar J; Leyva E; Loredo-Carrillo SE; Cárdenas-Chaparro A; Martínez-Richa A; Hernández-López H; Araujo-Huitrado JG; Granados-López AJ; López-Hernández Y; López JA
Curr Org Synth; 2024; 21(4):559-570. PubMed ID: 37078356
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and in vitro evaluation of potential anticancer activity of mono- and bis-1,2,3-triazole derivatives of bis-alkynes.
Elamari H; Slimi R; Chabot GG; Quentin L; Scherman D; Girard C
Eur J Med Chem; 2013 Feb; 60():360-4. PubMed ID: 23314049
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of 3-amino-1,2,4-triazole derivatives as potential anticancer compounds.
Grytsai O; Valiashko O; Penco-Campillo M; Dufies M; Hagege A; Demange L; Martial S; Pagès G; Ronco C; Benhida R
Bioorg Chem; 2020 Nov; 104():104271. PubMed ID: 32992279
[TBL] [Abstract][Full Text] [Related]
13. Efficient access to domain-integrated estradiol-flavone hybrids via the corresponding chalcones and their in vitro anticancer potential.
Molnár B; Gopisetty MK; Nagy FI; Adamecz DI; Kása Z; Kiricsi M; Frank É
Steroids; 2022 Nov; 187():109099. PubMed ID: 35970223
[TBL] [Abstract][Full Text] [Related]
14. Secosteroid thiosemicarbazides and secosteroid-1,2,4-triazoles as antiproliferative agents targeting breast cancer cells: Synthesis and biological evaluation.
Ilovaisky AI; Scherbakov AM; Chernoburova EI; Povarov AA; Shchetinina MA; Merkulova VM; Salnikova DI; Sorokin DV; Bozhenko EI; Zavarzin IV; Terent'ev AO
J Steroid Biochem Mol Biol; 2023 Nov; 234():106386. PubMed ID: 37666392
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, in vitro anticancer and antibacterial activities and in silico studies of new 4-substituted 1,2,3-triazole-coumarin hybrids.
Kraljević TG; Harej A; Sedić M; Pavelić SK; Stepanić V; Drenjančević D; Talapko J; Raić-Malić S
Eur J Med Chem; 2016 Nov; 124():794-808. PubMed ID: 27639370
[TBL] [Abstract][Full Text] [Related]
16. Hybrids of 4-hydroxy derivatives of goniothalamin and piplartine bearing a diester or a 1,2,3-triazole linker as antiproliferative agents.
Grigolo TA; Braga CB; Ornelas C; Russowsky D; Ferreira-Silva GA; Ionta M; Pilli RA
Bioorg Chem; 2021 Nov; 116():105292. PubMed ID: 34509797
[TBL] [Abstract][Full Text] [Related]
17. Click chemistry-based synthesis and anticancer activity evaluation of novel C-14 1,2,3-triazole dehydroabietic acid hybrids.
Hou W; Luo Z; Zhang G; Cao D; Li D; Ruan H; Ruan BH; Su L; Xu H
Eur J Med Chem; 2017 Sep; 138():1042-1052. PubMed ID: 28759877
[TBL] [Abstract][Full Text] [Related]
18. The In Vitro Anticancer Activity and Potential Mechanism of Action of 1-[(1R,2S)-2-fluorocyclopropyl]Ciprofloxacin-(4-methyl/phenyl/benzyl-3- aryl)-1,2,4-triazole-5(4H)-thione Hybrids.
Zhang YZ; Liu HL; He QS; Xu Z
Curr Top Med Chem; 2020; 20(16):1493-1498. PubMed ID: 32156237
[TBL] [Abstract][Full Text] [Related]
19. Design, Synthesis and Antiproliferative Evaluation of Novel 1,2,4-Triazole/Schiff Base Hybrids with EGFR and B-RAF Inhibitory Activities.
El-Sherief HAM; Youssif BGM; Abdelazeem AH; Abdel-Aziz M; Abdel-Rahman HM
Anticancer Agents Med Chem; 2019; 19(5):697-706. PubMed ID: 30582484
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of novel 1,2,3-triazole-pyrimidine hybrids as potential anticancer agents.
Ma LY; Pang LP; Wang B; Zhang M; Hu B; Xue DQ; Shao KP; Zhang BL; Liu Y; Zhang E; Liu HM
Eur J Med Chem; 2014 Oct; 86():368-80. PubMed ID: 25180925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
